Literature DB >> 6411855

Alteration of membrane permeability in Bacillus subtilis by clofoctol.

F Yablonsky.   

Abstract

When Bacillus subtilis was treated with a bacteriostatic concentration of clofoctol [2-(2,4-dichlorobenzyl)-4-(tetramethyl-1,1,3,3-butyl)phenol], UV-absorbing material was released. Electron micrographs showed evidence of physical alteration of the bacterial envelope. The uptake of [14C]glutamate was strongly inhibited by clofoctol, and preloaded glutamate was found to leak from the bacteria. Clofoctol caused an immediate and dramatic decrease in the amount of intracellular ATP. This was neither the consequence of the stimulation of an ATPase, nor of the inhibition of bacterial respiration. Both the proton gradient and the potential gradient across the cytoplasmic membrane collapsed and this inhibition of energy metabolism was sufficient to account for the inhibition of growth by clofoctol. At the same bacteriostatic concentration complete permeabilization of the bacteria occurred.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411855     DOI: 10.1099/00221287-129-4-1089

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  5 in total

1.  Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.

Authors:  Minghua Wang; Joong Sup Shim; Ruo-Jing Li; Yongjun Dang; Qingli He; Manisha Das; Jun O Liu
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

2.  Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice.

Authors:  Sandrine Belouzard; Arnaud Machelart; Valentin Sencio; Thibaut Vausselin; Eik Hoffmann; Nathalie Deboosere; Yves Rouillé; Lowiese Desmarets; Karin Séron; Adeline Danneels; Cyril Robil; Loic Belloy; Camille Moreau; Catherine Piveteau; Alexandre Biela; Alexandre Vandeputte; Séverine Heumel; Lucie Deruyter; Julie Dumont; Florence Leroux; Ilka Engelmann; Enagnon Kazali Alidjinou; Didier Hober; Priscille Brodin; Terence Beghyn; François Trottein; Benoit Deprez; Jean Dubuisson
Journal:  PLoS Pathog       Date:  2022-05-19       Impact factor: 7.464

3.  Antimicrobial Activity and Mode of Action of Celastrol, a Nortriterpen Quinone Isolated from Natural Sources.

Authors:  Nayely Padilla-Montaño; Leandro de León Guerra; Laila Moujir
Journal:  Foods       Date:  2021-03-11

4.  In vitro Activity of Antivirulence Drugs Targeting the las or pqs Quorum Sensing Against Cystic Fibrosis Pseudomonas aeruginosa Isolates.

Authors:  Diletta Collalto; Giulia Giallonardi; Alessandra Fortuna; Carlo Meneghini; Ersilia Fiscarelli; Paolo Visca; Francesco Imperi; Giordano Rampioni; Livia Leoni
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 5.640

5.  Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the pqs Quorum-Sensing System of Pseudomonas aeruginosa.

Authors:  Francesca D'Angelo; Valerio Baldelli; Nigel Halliday; Paolo Pantalone; Fabio Polticelli; Ersilia Fiscarelli; Paul Williams; Paolo Visca; Livia Leoni; Giordano Rampioni
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.